437 related articles for article (PubMed ID: 32190778)
1. Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .
Samji NS; Heda R; Satapathy SK
Transl Gastroenterol Hepatol; 2020; 5():10. PubMed ID: 32190778
[TBL] [Abstract][Full Text] [Related]
2. NAFLD and liver transplantation: Disease burden, current management and future challenges.
Burra P; Becchetti C; Germani G
JHEP Rep; 2020 Dec; 2(6):100192. PubMed ID: 33163950
[TBL] [Abstract][Full Text] [Related]
3. Approach to prevention of non-alcoholic fatty liver disease after liver transplantation.
Sharma P; Arora A
Transl Gastroenterol Hepatol; 2020; 5():51. PubMed ID: 33073046
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
[TBL] [Abstract][Full Text] [Related]
5. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant.
Chandrakumaran A; Siddiqui MS
Gastroenterol Clin North Am; 2020 Mar; 49(1):165-178. PubMed ID: 32033762
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
[TBL] [Abstract][Full Text] [Related]
7. Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.
Khullar V; Dolganiuc A; Firpi RJ
World J Transplant; 2014 Jun; 4(2):81-92. PubMed ID: 25032097
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease and liver transplantation.
Khan RS; Newsome PN
Metabolism; 2016 Aug; 65(8):1208-23. PubMed ID: 26997540
[TBL] [Abstract][Full Text] [Related]
9. Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis.
Doycheva I; Thuluvath PJ
Transl Gastroenterol Hepatol; 2020; 5():38. PubMed ID: 32632389
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease after Liver Transplant.
Shetty A; Giron F; Divatia MK; Ahmad MI; Kodali S; Victor D
J Clin Transl Hepatol; 2021 Jun; 9(3):428-435. PubMed ID: 34221929
[TBL] [Abstract][Full Text] [Related]
11. Current status of liver transplantation for non-B non-C liver cirrhosis and hepatocellular carcinoma.
Nishio T; Ito T; Hata K; Taura K; Hatano E
Ann Gastroenterol Surg; 2023 Jan; 7(1):42-52. PubMed ID: 36643372
[TBL] [Abstract][Full Text] [Related]
12. Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the Anesthesiologist.
Sharma S; Stine JG; Verbeek T; Bezinover D
J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2616-2627. PubMed ID: 34391652
[TBL] [Abstract][Full Text] [Related]
13. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management.
Battistella S; D'Arcangelo F; Grasso M; Zanetto A; Gambato M; Germani G; Senzolo M; Russo FP; Burra P
Clin Mol Hepatol; 2023 Feb; 29(Suppl):S286-S301. PubMed ID: 36577425
[TBL] [Abstract][Full Text] [Related]
17. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge.
Steggerda JA; Mahendraraj K; Todo T; Noureddin M
World J Gastroenterol; 2020 Jul; 26(28):4018-4035. PubMed ID: 32821068
[TBL] [Abstract][Full Text] [Related]
18. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
[TBL] [Abstract][Full Text] [Related]
19. Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation.
Maiwall R; Gupta M
Transl Gastroenterol Hepatol; 2020; 5():18. PubMed ID: 32258522
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Steatohepatitis: A Review.
Sheka AC; Adeyi O; Thompson J; Hameed B; Crawford PA; Ikramuddin S
JAMA; 2020 Mar; 323(12):1175-1183. PubMed ID: 32207804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
